CTI BioPharma to Present at the 18th Annual Needham Healthcare Conference on Wednesday, Apr. 10

SEATTLE, April 3, 2019 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) CTIC today announced that management will provide a corporate overview at the 18^th Annual Needham Healthcare Conference at 9:20 a.m. EDT at the Westin New York Grand Central.

Presentation details:

The presentation will be webcast live and available for replay from the Investors section of CTI BioPharma's website at www.ctibiopharma.com.

About CTI BioPharma Corp.
CTI BioPharma Corp. is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers that offer a unique benefit to patients and healthcare providers. The CTI BioPharma lead product candidate, pacritinib, is being developed for the treatment of patients with myelofibrosis. CTI BioPharma is headquartered in Seattle, Washington.

CTI BioPharma Investor Contacts:

Argot Partners
Maeve Conneighton/Maghan Meyers  
+1-212-600-1902
CTI@argotpartners.com

SOURCE CTI BioPharma Corp.